Skip to Main Content

Author Details

David Hudesman
NYU Grossman School of Medicine
2002
62
23
PMIDPaper TitleJournal TitlePublished Year
36191274The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.Am J Gastroenterol2023
37886705Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission.Crohns Colitis 3602023
37772156Choosing Among Small Molecule and Biologic Therapies for Patients With Ulcerative Colitis.Gastroenterol Hepatol (N Y)2023
35380664Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.Inflamm Bowel Dis2023
35700276Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.Inflamm Bowel Dis2023
37124374Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease.Therap Adv Gastroenterol2023
37410929Preoperative Risk Factors for Adverse Events in Adults Undergoing Bowel Resection for Inflammatory Bowel Disease: 15-Year Assessment of the American College of Surgeons National Surgical Quality Improvement Program.Am J Gastroenterol2023
36702534Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis.Inflamm Bowel Dis2023
36792106A Joint Effort: Improving the Identification of Spondyloarthritis in Patients With Inflammatory Bowel Disease.J Rheumatol2023
36336750Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.Patient2023
35905032Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.Inflamm Bowel Dis2023
33039584Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.Clin Gastroenterol Hepatol2022
35403000Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease.Lancet Rheumatol2022
35416799Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.Am J Gastroenterol2022
36348637COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.Therap Adv Gastroenterol2022
35879231Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis.Aliment Pharmacol Ther2022
35262671Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy.Inflamm Bowel Dis2022
34436563The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD).Inflamm Bowel Dis2022
32445049Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.Dig Dis Sci2021
36777067Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States.Crohns Colitis 3602021
36776648Serum Ustekinumab Concentrations Are Associated With Remission in Crohn's Disease Defined by a Serum-Based Endoscopic Healing Index.Crohns Colitis 3602021
34797226Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.Am J Gastroenterol2021
34279600Health Maintenance Consensus for Adults With Inflammatory Bowel Disease.Inflamm Bowel Dis2021
33474649Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.Dig Dis Sci2021
33359089Single-Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells From Ulcerative Colitis Patients.Gastroenterology2021
33386740Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease.Inflamm Bowel Dis2021
32578843From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.Inflamm Bowel Dis2021
32793977Prevalence, Predictors, and Disease Activity of Sacroiliitis Among Patients with Crohn's Disease.Inflamm Bowel Dis2021
31522323Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.Dig Dis Sci2020
32062041Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol2020
31866067Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.Cell2020
32002688First-Line Biologics or Small Molecules in Inflammatory Bowel Disease: a Practical Guide for the Clinician.Curr Gastroenterol Rep2020
33357400Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.Cell2020
32745306A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares.Aliment Pharmacol Ther2020
32656800Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's disease.Aliment Pharmacol Ther2020
32780484Systematic review with meta-analysis: a history of smoking is not associated with a higher risk of pouchitis.Aliment Pharmacol Ther2020
32296895A clinical and radiographic model to predict surgery for acute small bowel obstruction in Crohn's disease.Abdom Radiol (NY)2020
32266326Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study.BMC Rheumatol2020
32348641Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.N Engl J Med2020
32393973Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.Inflamm Bowel Dis2020
31302306Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol2020
30312400Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.Inflamm Bowel Dis2019
31182797IFN-I and IL-22 mediate protective effects of intestinal viral infection.Nat Microbiol2019
31050734Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.Inflamm Bowel Dis2019
30268561Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol2019
30625408Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.Clin Gastroenterol Hepatol2019
29509927Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Major Abdominal Operations for Inflammatory Bowel Disease: Retrospective Multicenter Cohort Study.Inflamm Bowel Dis2018
29946178Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Am J Gastroenterol2018
29857091Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.Gastroenterology2018
29855655The nocebo effect and patient perceptions of biosimilars in inflammatory bowel disease.Eur J Clin Pharmacol2018
  • 1 - 50 of 62

Recommended Authors

Sunhee Park
University of California Irvine
Career Start Year 2014
Number of shared co-authors 8
Terrence C Lee
University of California San Diego
Career Start Year 2013
Number of shared co-authors 0
Vivek A Rudrapatna
University of California san francisco
Career Start Year 2012
Number of shared co-authors 8
Phillip Gu
Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 8
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 2
Trilokesh D Kidambi
City of Hope National Medical Center
Career Start Year 2010
Number of shared co-authors 0
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 1
Christina Ha
Cedars-Sinai Medical Center
Career Start Year 2009
Number of shared co-authors 12
Brendan Boyle
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 1
Berkeley N Limketkai
university of california los angeles School of Medicine
Career Start Year 2008
Number of shared co-authors 11
Elizabeth Esterberg
RTI Health Solutions
Career Start Year 2008
Number of shared co-authors 0
Ajitha Mannalithara
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Michael Sey
Western University
Career Start Year 2006
Number of shared co-authors 3
Jessica J Lee
Center for Drug Evaluation and Research
Career Start Year 2006
Number of shared co-authors 1
Daniel J Stein
Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Harry Sokol
Paris Center for Microbiome Medicine
Career Start Year 2004
Number of shared co-authors 2
Martijn G H van Oijen
University of Amsterdam, Cancer Center Amsterdam
Career Start Year 2004
Number of shared co-authors 1
Ashish Atreja
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 7
Nimisha K Parekh
University of California Irvine
Career Start Year 2001
Number of shared co-authors 11
Uma Mahadevan
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 14
Florian Grimpen
Royal Brisbane and Women's Hospital
Career Start Year 2000
Number of shared co-authors 0
William A Faubion
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 9
Brennan M R Spiegel
Cedars-Sinai Center for Outcomes Research and Education (CS-CORE)
Career Start Year 1992
Number of shared co-authors 7
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Joseph A Murray
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 9
Nghia H Nguyen
University of California
Career Start Year 1990
Number of shared co-authors 11
Dermot P B McGovern
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1987
Number of shared co-authors 14
Athos Bousvaros
Boston Children's Hospital
Career Start Year 1985
Number of shared co-authors 3
Felicity T Enders
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 4
Phillip Fleshner
F. Widjaja Inflammatory Bowel Disease Institute
Career Start Year 1981
Number of shared co-authors 14

Collaborators

Dana J Lukin
Jill Roberts Center for IBD
Co-authored papers 15
Corey A Siegel
Dartmouth-Hitchcock Medical Center
Co-authored papers 15
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 15
Arun Swaminath
Lenox Hill Hospital
Co-authored papers 14
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 14
Sunanda V Kane
Mayo Clinic
Co-authored papers 13
William J Sandborn
University of California San Diego
Co-authored papers 13
Bruce E Sands
Icahn School of Medicine at Mount Sinai
Co-authored papers 13
Edward V Loftus
Mayo Clinic College of Medicine and Science
Co-authored papers 13
Siddharth Singh
University of California San Diego
Co-authored papers 12
Brigid S Boland
University of California
Co-authored papers 12
Eugenia Shmidt
University of Minnesota
Co-authored papers 11
Robert Hirten
Co-authored papers 11
Farhad Peerani
University of Alberta
Co-authored papers 5
Khadija Chaudrey
Lahey Hospital and Medical Center
Co-authored papers 5
Neeraj Narula
Farncombe Family Digestive Health Research Institute, McMaster University
Co-authored papers 5
Diana Whitehead
Dartmouth-Hitchcock Medical Center
Co-authored papers 4
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers 4
John T Chang
University of California San Diego
Co-authored papers 3
Benjamin L Cohen
Co-authored papers 3
Ronghui Xu
University of California San Diego
Co-authored papers 2
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Ashwin N Ananthakrishnan
Co-authored papers 2
Wasif M Abidi
Co-authored papers 1
Richard Bonneau
Center for Computational Biology (CCB), Flatiron Institute, Simons Foundation
Co-authored papers 1
Marla C Dubinsky
Co-authored papers 1
Mark J Mulligan
Co-authored papers 1
Jenny Sauk
university of california los angeles School of Medicine
Co-authored papers 1
Kelly V Ruggles
Co-authored papers 1
Graham E Quinn
Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Release 1.2